75N93024C00052

BAA2023-1 RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number: 75N93024C00052
Issuing organization: National Institutes of Health · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: BAA2023-1 RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES
Source: USASpending (Federal)
Source ID: usa-75N93024C00052

Details

Location: United States

Description

BAA2023-1 RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES Awarded to: CLEAR LABS INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT

Dates

Publication: 2024/08/01 12:00:00 AM UTC
Closing date: 2026/12/31 12:00:00 AM UTC

Estimated value

$2.4M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-09-02, 1:06:34 a.m.

Data refreshed every 2 hours